Financial: Another Side Effect of Cancer Treatment

Closing in on cancer
October 3, 2017
Multiple sclerosis: Vitamin D deficiency may predict onset
October 3, 2017
Show all

Financial: Another Side Effect of Cancer Treatment

There are ways to navigate the high cost of treatment.

All too many cancer patients realize that the high cost of cancer treatment can end up as an unexpected side effect of treatment. In fact, some patients go into debt while trying to save their own life. This has become so common that it now has a name: financial toxicity. This economic hardship can be incurred from:

  • Treatment
  • Transportation costs
  • Childcare costs
  • Losing a job
  • Loss of income

It might not come as a surprise, then, that upwards of 60% of cancer patients experience distress, a situation that in turn influences the well-being of patients and their families. Cancer care experts are now realizing that the emotional distress surrounding cancer treatment is such that the care team for patients should be monitoring and taking steps to minimize this issue for patients. For example, the American Cancer Society offers tools that cancer patients can utilize: here.

If financial toxicity is a core part of a patient’s distress, it’s good to know that BioPlus Specialty Pharmacy provides a department that assists and supports patients with ways to connect with financial resources. In short, cancer patients do not have to walk this path alone, BioPlus is here to help.

Source

National Comprehensive Cancer Network. Distress screening in oncology leads to better doctor-patient relationships and improved outcomes. http://www.newswise.com/articles/view/663951/?sc=sphn

Read full article: Financial: Another Side Effect of Cancer Treatment

Read Full Article: Financial: Another Side Effect of Cancer Treatment

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.